Get the Stockscreener App
2.93
10.15%
0.27
Pre-market:
2.80
-0.13
-4.44%
Intelligent Bio Solutions Inc stock is traded at $2.93, with a volume of 345.07K.
It is up +10.15% in the last 24 hours and down -14.58% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
See More
Previous Close:
$2.66
Open:
$2.82
24h Volume:
345.07K
Relative Volume:
2.75
Market Cap:
$5.86M
Revenue:
$3.58M
Net Income/Loss:
$-11.33M
P/E Ratio:
-0.2672
EPS:
-10.9665
Net Cash Flow:
$-9.75M
1W Performance:
+19.11%
1M Performance:
-14.58%
6M Performance:
-72.87%
1Y Performance:
-75.38%
1-Day Range:
$2.60
$3.00
1-Week Range:
$2.45
$3.007
52-Week Range:
$2.42
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
2.93 | 5.32M | 3.58M | -11.33M | -9.75M | -10.97 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio : Investor DeckApril 2026 - marketscreener.com
Intelligent Bio Solutions (INBS) Launches Study to Enhance Drug Screening Speed - GuruFocus
Intelligent Bio Solutions Inc. Launches Validation Study to Achieve Sub-3-Minute Results in Roadside Drug Testing Technology - Quiver Quantitative
Fingerprint drug test aims for under-3-minute roadside results - Stock Titan
Intelligent Bio Solutions Updates Investor Presentation and Share Count - TipRanks
Intelligent Bio Solutions (NASDAQ: INBS) posts new investor deck and share update - Stock Titan
INBS completes penetration testing for FDA 510(k) submission By Investing.com - Investing.com India
Intelligent Bio Solutions (INBS) Enhances Security Ahead of FDA Submission - GuruFocus
Intelligent Bio Solutions Inc. Advances Fda 510(K) Submission And Completes Penetration Testing - marketscreener.com
INBS completes penetration testing for FDA 510(k) submission - Investing.com
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified - The Manila Times
No major security flaws found as Intelligent Bio readies FDA filing - Stock Titan
How cyclical is Intelligent Bio Solutions Incs revenue stream2026 Price Swings & Smart Money Movement Tracker - baoquankhu1.vn
INBS Stock Price, Quote & Chart | INTELLIGENT BIO SOLUTIONS IN (NASDAQ:INBS) - ChartMill
INBS Advances FDA Approval with Successful Initial Study - GuruFocus
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market - Bitget
Intelligent Bio Solutions Completes Clinical Cut-Off Study - TradingView — Track All Markets
INBS Stock Falls After Clinical Study Win: FDA Progress Fails To Lift Shares - Stocktwits
A fingerprint drug test moved closer to a U.S. launch after codeine study - Stock Titan
Published on: 2026-03-31 09:14:37 - baoquankhu1.vn
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant - Bitget
Intelligent Bio Solutions receives European patent for drug testing tech - Investing.com
Intelligent Bio Solutions receives European patent for drug testing tech By Investing.com - Investing.com India
A fingerprint sweat drug test just won its 8th European patent - stocktitan.net
Intelligent Bio Solutions Inc. Announces 2026 Restricted Stock Award Agreements and Incentive Plan Updates - Minichart
Intelligent Bio Solutions Grants Equity Awards, Updates ATM Capacity - The Globe and Mail
Intelligent Bio Solutions grants equity to CEO Harry Simeonidis and CFO Spiro Sakiris - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) details new equity awards, ATM capacity - Stock Titan
INBS (NASDAQ: INBS) files ATM with Ladenburg to raise up to $3.97M - Stock Titan
If You Invested $1,000 in Intelligent Bio Solutions Inc (INBS) - Stock Titan
INBS (INBS) director receives 5,000 restricted shares in equity award - stocktitan.net
Intelligent Bio Solutions (NASDAQ: INBS) grants director 5,000 restricted shares - Stock Titan
INBS (INBS) CFO receives time- and performance-based restricted stock grants - Stock Titan
Director at Intelligent Bio Solutions (INBS) granted 5,000 shares - Stock Titan
Director at Intelligent Bio Solutions (INBS) awarded 5,000 restricted shares - Stock Titan
INBS (INBS) CEO receives time- and performance-based restricted stock grants - Stock Titan
Intelligent Bio Solutions Inc.: Fundamental Analysis and Financial Ratings | 12Q | US36151G7097 - marketscreener.com
Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Why Is INBS Stock Rising Today? - Dailyhunt
Intelligent Bio Solutions Inc. (INBS) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Why Intelligent Bio Solutions Inc. stock is rated strong buyJuly 2025 Short Interest & Weekly High Return Stock Opportunities - Naître et grandir
How Intelligent Bio Solutions Inc. stock reacts to global recession fearsWeekly Profit Analysis & Target Return Focused Picks - Naître et grandir
Intelligent Bio Solutions announces reverse stock split - MSN
Jobs Data: Should you buy the dip on Intelligent Bio Solutions IncPortfolio Performance Summary & Weekly Breakout Watchlists - baoquankhu1.vn
Why Did INBS Stock Fall 17% Today? - Stocktwits
Intelligent Bio Solutions Scales Manufacturing to Fuel Growth and U.S. Ambitions - AD HOC NEWS
HealthEquity (NASDAQ:HQY) & Intelligent Bio Solutions (NASDAQ:INBS) Head to Head Comparison - Defense World
Jobs Data: How cyclical is Intelligent Bio Solutions Incs revenue stream2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
INBS receives first reader shipment from Syrma Johari partnership By Investing.com - Investing.com Australia
INBS receives first reader shipment from Syrma Johari partnership - Investing.com
Intelligent Bio Solutions Expands Manufacturing Capacity and Deployment - TipRanks
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):